FDA Orange Book
Is there a generic for Yonsa?
Yonsa contains abiraterone acetate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Yonsa (abiraterone acetate). The Orange Book shows its last listed patent expires May 20, 2034.
Run it in Rivvi
Map Yonsa and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Yonsa products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 125MG | Marketed (Rx) | None | 0 | None |
NDA 210308, held by SUN PHARMACEUTICAL INDUSTRIES LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Yonsa patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9889144 | March 17, 2034 | Drug product | None | 210308 |
| 10292990 | May 20, 2034 | Method of use | U-2535 | 210308 |
Yonsa NDC codes
Questions
Is there a generic for Yonsa?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Yonsa (abiraterone acetate). The Orange Book shows its last listed patent expires May 20, 2034.
What is the generic name for Yonsa?
The active ingredient in Yonsa is abiraterone acetate, per the FDA Orange Book.
When does the Yonsa patent expire?
The last patent listed for Yonsa in the Orange Book expires May 20, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.